Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Selling, general and administrative $ 2,116,266 $ 2,078,878
Research and development 1,096,286
Loss from operations (3,212,552) (2,078,878)
Other income (expense):    
Change in fair value of warrant liabilities (46,870) 785,297
Interest expense, net (6,388)  
Other (expense) income, net (53,258) 785,297
Loss before income taxes (3,265,810) (1,293,581)
Provision for income taxes
Net loss from continuing operations (3,265,810) (1,293,581)
Net loss from discontinued operations (271,869) (280,659)
Net loss $ (3,537,679) $ (1,574,240)
Weighted-average common shares outstanding, basic (in Shares) 26,073,036 23,008,371
Basic and diluated loss per share from continuing operations (in Dollars per share) $ (0.13) $ (0.06)
Basic and diluted loss per share from discontinuing operations (in Dollars per share) $ (0.01) $ (0.01)
Comprehensive loss:    
Net loss $ (3,537,679) $ (1,574,240)
Foreign currency translation (2,483) (1,574,240)
Comprehensive loss $ (3,540,162) $ (3,148,480)